Pustular exacerbation of psoriasis due to fexofenadine [20]

Clinical and Experimental Dermatology

Volumn 31, Issue 3, 2006, Pages 477-478

  Saraswat, A ^a   Saraswat, M ^a  

^a Era's Lucknow Medical College   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CETIRIZINE; EMOLLIENT AGENT; FEXOFENADINE; IBUPROFEN; KERATOLYTIC AGENT; METHOTREXATE; PHENIRAMINE;

ADULT; ANAMNESIS; BODY SURFACE; BURNING SENSATION; CASE REPORT; CLINICAL FEATURE; DISEASE EXACERBATION; DRUG DOSE REDUCTION; ERYTHEMA; HUMAN; LETTER; MALAISE; MALE; PRIORITY JOURNAL; PROVOCATION TEST; PRURITUS; PSORIASIS VULGARIS; PUSTULAR PSORIASIS; PUSTULE; URTICARIA;

ACUTE DISEASE; DRUG ERUPTIONS; HISTAMINE H1 ANTAGONISTS; HUMANS; MALE; MIDDLE AGED; PSORIASIS; TERFENADINE;

EID: 33645371780     PISSN: 03076938     EISSN: 13652230     Source Type: Journal    
DOI: 10.1111/j.1365-2230.2006.02104.x     Document Type: Letter

References (5)

1. Aventis Pharmaceuticals Inc. Allegra (Fexofenadine HCI) factsheet New Jersey : Sanofi Aventis, 2003
2. Abel EA DiCicco LM Orenberg EK et al. Drugs in exacerbation of psoriasis J Am Acad Dermatol 1986 15 1007 22
3. Saissi EH Beau-Salinas H Jonville-Bera AP et al. Drugs associated with acute generalized exanthematic pustulosis Ann Dermatol Venereol 2003 130 612 18
4. Navaratnam AE Gebauer KA Terfenadine-induced exacerbation of psoriasis Clin Exp Dermatol 1990 15 78
5. Harrison PV Stones RN Severe exacerbation of psoriasis due to terfenadine Clin Exp Dermatol 1988 13 275